
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $1.5B | $3.4B | $9.1B | $5.9B | $5.5B | |
Revenue Growth (YoY) | -29.04% | 135.27% | 162.42% | -34.66% | -7.71% | |
Cost of Revenues | $1B | $1.5B | $3.1B | $3.2B | $3.5B | |
Gross Profit | $431M | $1.9B | $6B | $2.7B | $2B | |
Gross Profit Margin | 29.4% | 56.16% | 66.3% | 46.43% | 36.55% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $106M | $270M | $396M | $279M | $302M | |
Other Inc / (Exp) | -- | -$2M | $29M | $12M | $3M | |
Operating Expenses | $135M | $371M | $791M | $592M | $609M | |
Operating Income | $296M | $1.6B | $5.2B | $2.2B | $1.4B | |
Net Interest Expenses | $54M | $62M | $70M | $26M | $44M | |
EBT. Incl. Unusual Items | $242M | $1.5B | $5.2B | $2.1B | $1.3B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $41M | $344M | $1.1B | $503M | $224M | |
Net Income to Company | $201M | $1.2B | $4.1B | $1.6B | $1.1B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $201M | $1.2B | $4.1B | $1.6B | $1.1B | |
Basic EPS (Cont. Ops) | $0.50 | $2.30 | $5.09 | $2.14 | $1.51 | |
Diluted EPS (Cont. Ops) | $0.50 | $2.29 | $5.08 | $2.13 | $1.50 | |
Weighted Average Basic Share | $399M | $503M | $796M | $756M | $742M | |
Weighted Average Diluted Share | $401M | $504M | $799M | $760M | $745M | |
EBITDA | $691M | $2.3B | $6.9B | $3.9B | $3.3B | |
EBIT | $296M | $1.6B | $5.2B | $2.2B | $1.5B | |
Revenue (Reported) | $1.5B | $3.4B | $9.1B | $5.9B | $5.5B | |
Operating Income (Reported) | $296M | $1.6B | $5.2B | $2.2B | $1.4B | |
Operating Income (Adjusted) | $296M | $1.6B | $5.2B | $2.2B | $1.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $460M | $1.7B | $1.8B | $1.4B | $1.9B | |
Revenue Growth (YoY) | 19.03% | 265% | 5.84% | -19.36% | 32.87% | |
Cost of Revenues | $248M | $691M | $736M | $835M | $1B | |
Gross Profit | $212M | $988M | $1B | $598M | $903M | |
Gross Profit Margin | 46.09% | 58.85% | 58.58% | 41.73% | 47.43% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $29M | $107M | $69M | $75M | $92M | |
Other Inc / (Exp) | -- | $2M | -$2M | -$1M | -- | |
Operating Expenses | $37M | $191M | $162M | $157M | $201M | |
Operating Income | $175M | $797M | $879M | $441M | $702M | |
Net Interest Expenses | $12M | $21M | $5M | $3M | $45M | |
EBT. Incl. Unusual Items | $163M | $778M | $872M | $437M | $657M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $37M | $170M | $195M | $85M | $141M | |
Net Income to Company | $126M | $608M | $677M | $352M | $516M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $126M | $608M | $677M | $352M | $516M | |
Basic EPS (Cont. Ops) | $0.32 | $0.75 | $0.88 | $0.47 | $0.68 | |
Diluted EPS (Cont. Ops) | $0.31 | $0.74 | $0.88 | $0.47 | $0.68 | |
Weighted Average Basic Share | $399M | $810M | $764M | $750M | $756M | |
Weighted Average Diluted Share | $402M | $814M | $768M | $755M | $761M | |
EBITDA | $269M | $1.2B | $1.3B | $889M | $1.2B | |
EBIT | $175M | $809M | $893M | $460M | $713M | |
Revenue (Reported) | $460M | $1.7B | $1.8B | $1.4B | $1.9B | |
Operating Income (Reported) | $175M | $797M | $879M | $441M | $702M | |
Operating Income (Adjusted) | $175M | $809M | $893M | $460M | $713M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.5B | $4.7B | $9.1B | $5.6B | $5.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1B | $2B | $3.1B | $3.3B | $3.6B | |
Gross Profit | $517.3M | $2.7B | $6.1B | $2.3B | $2.3B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $101.6M | $348M | $389M | $286M | $319M | |
Other Inc / (Exp) | -$176K | -- | $56M | $4M | $4M | |
Operating Expenses | $132.6M | $523M | $793M | $588M | $653M | |
Operating Income | $384.6M | $2.2B | $5.3B | $1.7B | $1.6B | |
Net Interest Expenses | $51.8M | $71M | $54M | $24M | $86M | |
EBT. Incl. Unusual Items | $332.9M | $2.1B | $5.3B | $1.7B | $1.6B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $59.8M | $477M | $1.1B | $393M | $280M | |
Net Income to Company | $273.1M | $1.6B | $4.1B | $1.3B | $1.3B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $273.1M | $1.6B | $4.1B | $1.3B | $1.3B | |
Basic EPS (Cont. Ops) | $0.69 | $2.15 | $5.24 | $1.73 | $1.72 | |
Diluted EPS (Cont. Ops) | $0.68 | $2.14 | $5.22 | $1.71 | $1.71 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $773.5M | $3.2B | $7B | $3.5B | $3.6B | |
EBIT | $384.7M | $2.2B | $5.3B | $1.8B | $1.7B | |
Revenue (Reported) | $1.5B | $4.7B | $9.1B | $5.6B | $5.9B | |
Operating Income (Reported) | $384.6M | $2.2B | $5.3B | $1.7B | $1.6B | |
Operating Income (Adjusted) | $384.7M | $2.2B | $5.3B | $1.8B | $1.7B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $460M | $1.7B | $1.8B | $1.4B | $1.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $248M | $691M | $736M | $835M | $1B | |
Gross Profit | $212M | $988M | $1B | $598M | $903M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $29M | $107M | $69M | $75M | $92M | |
Other Inc / (Exp) | -- | $2M | -$2M | -$1M | -- | |
Operating Expenses | $37M | $191M | $162M | $157M | $201M | |
Operating Income | $175M | $797M | $879M | $441M | $702M | |
Net Interest Expenses | $12M | $21M | $5M | $3M | $45M | |
EBT. Incl. Unusual Items | $163M | $778M | $872M | $437M | $657M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $37M | $170M | $195M | $85M | $141M | |
Net Income to Company | $126M | $608M | $677M | $352M | $516M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $126M | $608M | $677M | $352M | $516M | |
Basic EPS (Cont. Ops) | $0.32 | $0.75 | $0.88 | $0.47 | $0.68 | |
Diluted EPS (Cont. Ops) | $0.31 | $0.74 | $0.88 | $0.47 | $0.68 | |
Weighted Average Basic Share | $399M | $810M | $764M | $750M | $756M | |
Weighted Average Diluted Share | $402M | $814M | $768M | $755M | $761M | |
EBITDA | $269M | $1.2B | $1.3B | $889M | $1.2B | |
EBIT | $175M | $809M | $893M | $460M | $713M | |
Revenue (Reported) | $460M | $1.7B | $1.8B | $1.4B | $1.9B | |
Operating Income (Reported) | $175M | $797M | $879M | $441M | $702M | |
Operating Income (Adjusted) | $175M | $809M | $893M | $460M | $713M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $140M | $1B | $673M | $956M | $2B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $216M | $922M | $1.1B | $723M | $820M | |
Inventory | $15M | $39M | $63M | $59M | $46M | |
Prepaid Expenses | -- | -- | -- | $11M | $14M | |
Other Current Assets | $2M | $7M | $9M | $1M | $1M | |
Total Current Assets | $416M | $2.1B | $2.2B | $2B | $3.3B | |
Property Plant And Equipment | $4.1B | $17.7B | $17.9B | $18.3B | $18.1B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | $20M | $36M | $82M | $136M | |
Total Assets | $4.5B | $19.9B | $20.2B | $20.4B | $21.6B | |
Accounts Payable | $11M | $94M | $27M | $60M | $59M | |
Accrued Expenses | $111M | $321M | $358M | $360M | $352M | |
Current Portion Of Long-Term Debt | $188M | -- | -- | $575M | -- | |
Current Portion Of Capital Lease Obligations | $4M | $83M | $120M | $122M | $122M | |
Other Current Liabilities | -- | $159M | -- | -- | $17M | |
Total Current Liabilities | $390M | $1.2B | $1.2B | $1.7B | $1.1B | |
Long-Term Debt | $946M | $3.1B | $2.2B | $1.6B | $3.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.3B | $8.2B | $7.5B | $7.4B | $8.5B | |
Common Stock | $48M | $89M | $77M | $75M | $74M | |
Other Common Equity Adj | $2M | $1M | $13M | $11M | $12M | |
Common Equity | $2.2B | $11.7B | $12.7B | $13B | $13.1B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $2.2B | $11.7B | $12.7B | $13B | $13.1B | |
Total Liabilities and Equity | $4.5B | $19.9B | $20.2B | $20.4B | $21.6B | |
Cash and Short Terms | $140M | $1B | $673M | $956M | $2B | |
Total Debt | $1.1B | $3.1B | $2.2B | $2.2B | $3.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $173.7M | $1.4B | $973M | $1.3B | $186M | |
Short Term Investments | -- | -- | -- | $250M | -- | |
Accounts Receivable, Net | $198.6M | $1B | $628M | $656M | $940M | |
Inventory | $15.9M | $41M | $56M | $52M | $57M | |
Prepaid Expenses | -- | -- | -- | -- | $21M | |
Other Current Assets | $832K | $5M | $7M | $10M | $1.3B | |
Total Current Assets | $411.9M | $2.6B | $2B | $2.6B | $1.4B | |
Property Plant And Equipment | $4.1B | $17.7B | $18B | $18.3B | $22.3B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $128K | $26M | $35M | $84M | $170M | |
Total Assets | $4.6B | $20.3B | $20.1B | $21B | $24B | |
Accounts Payable | $17.2M | $41M | $60M | $64M | $144M | |
Accrued Expenses | $95.8M | $321M | $443M | $378M | $487M | |
Current Portion Of Long-Term Debt | $100M | $25M | -- | $575M | -- | |
Current Portion Of Capital Lease Obligations | $3.9M | $77M | $122M | $123M | $124M | |
Other Current Liabilities | -- | $372M | -- | $2M | $96M | |
Total Current Liabilities | $315.1M | $1.7B | $1.2B | $1.7B | $1.6B | |
Long-Term Debt | $946.1M | $3.1B | $2.2B | $2.1B | $4.3B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.2B | $8.6B | $7.5B | $7.9B | $9.7B | |
Common Stock | $47.8M | $89M | $76M | $75M | $76M | |
Other Common Equity Adj | $2.3M | $5M | $13M | $11M | $16M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -$1M | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $2.3B | $11.7B | $12.6B | $13.1B | $14.2B | |
Total Liabilities and Equity | $4.6B | $20.3B | $20.1B | $21B | $24B | |
Cash and Short Terms | $173.7M | $1.4B | $973M | $1.5B | $186M | |
Total Debt | $1B | $3.1B | $2.2B | $2.7B | $4.3B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $201M | $1.2B | $4.1B | $1.6B | $1.1B | |
Depreciation & Amoritzation | $391M | -- | $1.6B | $1.6B | $1.8B | |
Stock-Based Compensation | $40M | $52M | $73M | $57M | $61M | |
Change in Accounts Receivable | -$6M | -$229M | -$184M | $378M | -$108M | |
Change in Inventories | -$2M | $5M | -$24M | $4M | $13M | |
Cash From Operations | $778M | $1.7B | $5.5B | $3.7B | $2.8B | |
Capital Expenditures | $576M | $728M | $1.7B | $2.1B | $1.8B | |
Cash Acquisitions | -$9M | $1B | -- | -- | -- | |
Cash From Investing | -$584M | $313M | -$1.7B | -$2.1B | -$1.8B | |
Dividends Paid (Ex Special Dividend) | -$159M | -$780M | -$2B | -$890M | -$625M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $196M | $100M | -- | -- | $2B | |
Long-Term Debt Repaid | -$283M | -$290M | -$874M | -- | -$575M | |
Repurchase of Common Stock | -- | -- | -$1.3B | -$405M | -$455M | |
Other Financing Activities | -$10M | -$118M | -$29M | -$22M | -$56M | |
Cash From Financing | -$256M | -$1.1B | -$4.1B | -$1.3B | $279M | |
Beginning Cash (CF) | $214M | $152M | $1B | $683M | $965M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$62M | $894M | -$363M | $282M | $1.3B | |
Ending Cash (CF) | $152M | $1B | $683M | $965M | $2.3B | |
Levered Free Cash Flow | $202M | $939M | $3.7B | $1.6B | $1B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $30M | $1.2B | $209M | $220M | -- | |
Depreciation & Amoritzation | -- | $55M | $31M | $30M | -- | |
Stock-Based Compensation | $3M | $18M | $7M | $13M | -- | |
Change in Accounts Receivable | $15M | -$432M | $171M | $21M | -- | |
Change in Inventories | -$1M | -$7M | -$9M | $7M | -- | |
Cash From Operations | $179M | $879M | $646M | $558M | -- | |
Capital Expenditures | $151M | $474M | $597M | $481M | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$151M | -$472M | -$569M | -$480M | -- | |
Dividends Paid (Ex Special Dividend) | -$44M | -$484M | -$152M | -$156M | -- | |
Special Dividend Paid | -- | $450K | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$1M | -$1M | -$3M | -- | |
Repurchase of Common Stock | -- | -$313M | -$57M | -$140M | -- | |
Other Financing Activities | -- | -$1M | -- | $1M | -- | |
Cash From Financing | -$44M | -$795M | -$210M | -$297M | -- | |
Beginning Cash (CF) | $185M | $1.5B | $983M | $1.3B | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$16M | -$388M | -$133M | -$219M | -- | |
Ending Cash (CF) | $169M | $1.1B | $850M | $1.1B | -- | |
Levered Free Cash Flow | $28M | $405M | $49M | $77M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $273.1M | $1.6B | $4.1B | $1.3B | $1.3B | |
Depreciation & Amoritzation | -- | -- | $1.6B | $1.6B | $1.8B | |
Stock-Based Compensation | $35.2M | $61M | $70M | $52M | $64M | |
Change in Accounts Receivable | -$62.3M | -$303M | $319M | -$103M | -$77M | |
Change in Inventories | $1.3M | $4M | -$15M | $4M | -$2M | |
Cash From Operations | $863.1M | $2.7B | $5.6B | $3B | $3.1B | |
Capital Expenditures | $550.3M | $876M | $1.9B | $2.1B | $1.8B | |
Cash Acquisitions | $459K | -- | -- | -- | -$3.2B | |
Cash From Investing | -$548.9M | $167M | -$1.9B | -$2.3B | -$4.8B | |
Dividends Paid (Ex Special Dividend) | -$159.2M | -$1.2B | -$2B | -$612M | -$645M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $499M | $2.5B | |
Long-Term Debt Repaid | -$371M | -$204M | -$874M | $2M | -$825M | |
Repurchase of Common Stock | -- | -$184M | -$1.3B | -$286M | -$329M | |
Other Financing Activities | -$9.7M | -$118M | -$31M | -$20M | -$70M | |
Cash From Financing | -$343.9M | -$1.6B | -$4.2B | -$417M | $622M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$29.7M | $1.3B | -$474M | $315M | -$1.1B | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $312.8M | $1.8B | $3.7B | $947M | $1.3B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $156M | $1.8B | $886M | $572M | $516M | |
Depreciation & Amoritzation | -- | $74M | $60M | $60M | $36M | |
Stock-Based Compensation | $14M | $38M | $24M | $25M | $15M | |
Change in Accounts Receivable | $32M | -$489M | $617M | -$14M | -$4M | |
Change in Inventories | -$2M | -$9M | -$2M | $14M | -$8M | |
Cash From Operations | $469M | $2.2B | $2.1B | $1.4B | $1.1B | |
Capital Expenditures | $274M | $745M | $1.1B | $939M | $509M | |
Cash Acquisitions | -- | -- | -- | -- | -$3.2B | |
Cash From Investing | -$274M | -$741M | -$1B | -$1.2B | -$3.7B | |
Dividends Paid (Ex Special Dividend) | -$84M | -$940M | -$588M | -$314M | -$178M | |
Special Dividend Paid | -- | $860K | $370K | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $499M | $1B | |
Long-Term Debt Repaid | -$88M | -$3M | -$3M | -$3M | -$250M | |
Repurchase of Common Stock | -- | -$497M | -$326M | -$290M | -$24M | |
Other Financing Activities | -$6M | -$7M | -$8M | -$5M | -$20M | |
Cash From Financing | -$178M | -$1.4B | -$925M | -$112M | $528M | |
Beginning Cash (CF) | $337M | $2.5B | $1.7B | $2.3B | $2.3B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $17M | $23M | $167M | $114M | -$2.1B | |
Ending Cash (CF) | $354M | $2.5B | $1.8B | $2.4B | $221M | |
Levered Free Cash Flow | $195M | $1.5B | $1.1B | $475M | $635M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.